Follow The Filings

LTRN Lantern Pharma Inc.

Health Care, filed as LANTERN PHARMA INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • $105K
  • 1 reduce

In 2026 Q2 Murray Stahl trimmed Lantern Pharma.

Who owns LTRN

Sorted by value, long equity only, as of 2026 Q2.

History
Murray Stahl, Horizon Kinetics Asset Management <0.01% Reduce −4.6% 25,164 $105K History

1 current, options excluded

Insider trades

Open-market buys and sales by LTRN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All LTRN insider trades
  • $200K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Lee Troy Schalop Director
    Buy
    $100K 48,544 shares at $2.06 New stake
    Traded May 12 Filed May 14
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEF 14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 3.01 Filing Doc
8-K 1.01,3.02,9.01 Filing Doc
424B5 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
S-1 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,3.02,8.01,9.01 Filing Doc
10-K/A Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$15.96M -$20.78M -$17.12M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $43.34M $25.25M $10.8M
Total non-current assets * $306,291 $324,163 $232,639
Total assets $43.65M $25.57M $11.04M
Total current liabilities $2.68M $4.33M $4.5M
Total non-current liabilities * $61,496 $52,843 $0.00
Total equity $40.91M $21.19M $6.53M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$14.35M -$17.81M -$15.68M
Cash from investing -$0.93M $3.37M $11.06M
Cash from financing -$0.5M $0.067M $1.5M
Net change in cash -$15.81M -$14.43M -$3.09M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.